Skip to content
10-Q

Quarterly Report

Lucy Scientific Discovery Inc.

0001213900-24-013394

← back to feed
Filed
Feb 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Feb 13, 2024 17.65M sh
Shares Diluted Q2 2024 · Dec 31, 2023 17.65M sh
Shares Diluted Q2 2024 · Dec 31, 2023 17.61M sh
Shares Diluted Q2 2024 · Dec 31, 2022 10.44M sh
Shares Diluted Q2 2024 · Dec 31, 2022 10.44M sh
Stockholders Equity Q2 2024 · Dec 31, 2023 $81.16K
Stockholders Equity Q2 2024 · Sep 30, 2023 $2.7M
Stockholders Equity Q2 2024 · Jun 30, 2023 $4.68M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$6.78M
Stockholders Equity Q2 2024 · Sep 30, 2022 −$5.75M
Stockholders Equity Q2 2024 · Jun 30, 2022 −$4.78M
Current Liabilities Q2 2024 · Dec 31, 2023 $3.49M
Current Liabilities Q2 2024 · Jun 30, 2023 $2.71M
Total Liabilities Q2 2024 · Dec 31, 2023 $4.21M
Total Liabilities Q2 2024 · Jun 30, 2023 $4.1M
Current Assets Q2 2024 · Dec 31, 2023 $1.34M
Current Assets Q2 2024 · Jun 30, 2023 $3.82M
Total Assets Q2 2024 · Dec 31, 2023 $4.29M
Total Assets Q2 2024 · Jun 30, 2023 $8.78M
Eps Basic Q2 2024 · Dec 31, 2023 −$0.14
Eps Basic Q2 2024 · Dec 31, 2023 −$0.26
Eps Basic Q2 2024 · Dec 31, 2022 −$0.09
Eps Basic Q2 2024 · Dec 31, 2022 −$0.22
Sga Expense Q2 2024 · Dec 31, 2023 $868.33K
Sga Expense Q2 2024 · Dec 31, 2023 $2.25M
Sga Expense restated Q2 2024 · Dec 31, 2022 $182.04K
Sga Expense restated Q2 2024 · Dec 31, 2022 $810.68K
Net Income Q2 2024 · Dec 31, 2023 −$2.62M
Net Income Q2 2024 · Dec 31, 2023 −$4.62M
Net Income Q2 2024 · Sep 30, 2023 −$2M
Net Income Q2 2024 · Dec 31, 2022 −$933.81K
Net Income Q2 2024 · Dec 31, 2022 −$2.31M
Net Income Q2 2024 · Sep 30, 2022 −$1.37M
Gross Profit Q2 2024 · Dec 31, 2023 $5.82K
Gross Profit Q2 2024 · Dec 31, 2023 $5.82K
Revenue Q2 2024 · Dec 31, 2023 $9.68K
Revenue Q2 2024 · Dec 31, 2023 $9.68K